Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies

被引：0
|
作者：
P Hamberg
N Steeghs
W J Loos
D van de Biessen
M den Hollander
M Tascilar
J Verweij
H Gelderblom
S Sleijfer
机构：
[1] Erasmus University Medical Center Daniel Den Hoed Cancer Center,Department of Medical Oncology
[2] Leiden University Medical Center,Department of Medical Oncology
来源：
British Journal of Cancer | 2010年 / 102卷
关键词：
sunitinib; ifosfamide; pharmacokinetic; VEGF; drug-interaction; phase I;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1699 / 1706
页数：7
相关论文
共 50 条
  • [31] Phase I study of docetaxel plus ifosfamide in patients with advanced cancer
    G Marx
    C Lewis
    K Hall
    J Levi
    S Ackland
    British Journal of Cancer, 2002, 87 : 846 - 849
  • [32] Docetaxel-ifosfamide combination in patients with advanced breast cancer failing prior AnthracyclineBased regimens: Results of a phase I-II study
    Kosmas, C.
    Tsavaris, N.
    Mylonakis, N.
    Tsakonas, G.
    Gassiamis, A.
    Skopelitis, H.
    Polyzos, A.
    Malamos, N.
    Karabelis, A.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (03) : 322 - 331
  • [33] Phase I–II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer
    C Kosmas
    N Tsavaris
    N Malamos
    N Stavroyianni
    A Gregoriou
    S Rokana
    A Polyzos
    British Journal of Cancer, 2003, 88 : 1168 - 1174
  • [34] Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study
    Martin-Liberal, J.
    Lopez-Pousa, A.
    Martin Broto, J.
    Cubedo, R.
    Gallego, O.
    Brendel, E.
    Tirado, O. M.
    Garcia del Muro, X.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 287 - 294
  • [35] Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study
    J. Martín-Liberal
    A. López-Pousa
    J. Martín Broto
    R. Cubedo
    O. Gallego
    E. Brendel
    O. M. Tirado
    X. García del Muro
    Investigational New Drugs, 2014, 32 : 287 - 294
  • [36] A Phase I Clinical, Pharmacokinetic, and Pharmacodynamic Study of Weekly or Every Three Week Ixabepilone and Daily Sunitinib in Patients with Advanced Solid Tumors
    Montero, Alberto J.
    Kwon, Deukwoo
    Flores, Aurea
    Kovacs, Krisztina
    Trent, Jonathan C.
    Benedetto, Pasquale
    Rocha-Lima, Caio
    Merchan, Jaime R.
    CLINICAL CANCER RESEARCH, 2016, 22 (13) : 3209 - 3217
  • [37] A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies
    Justine Yang Bruce
    Jill M. Kolesar
    Hans Hammers
    Mark N. Stein
    Lakeesha Carmichael
    Jens Eickhoff
    Susan A. Johnston
    Kimberly A. Binger
    Jennifer L. Heideman
    Scott B. Perlman
    Robert Jeraj
    Glenn Liu
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 485 - 493
  • [38] A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma
    Rini, B.
    Redman, B.
    Garcia, J. A.
    Burris, H. A., III
    Li, S.
    Fandi, A.
    Beck, R.
    Jungnelius, U.
    Infante, J. R.
    ANNALS OF ONCOLOGY, 2014, 25 (09) : 1794 - 1799
  • [39] Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours
    C Kosmas
    N B Tsavaris
    A Polyzos
    N A Malamos
    M Katsikas
    M J Antonopoulos
    British Journal of Cancer, 2000, 82 : 300 - 307
  • [40] Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours
    Kosmas, C
    Tsavaris, NB
    Polyzos, A
    Malamos, NA
    Katsikas, M
    Antonopoulos, MJ
    BRITISH JOURNAL OF CANCER, 2000, 82 (02) : 300 - 307
12345